Article Versions Notes

Giunta EF, De Falco V, Vitiello PP, Guerrera LP, Suarato G, Napolitano R, Perrone A, Argenziano G, Franco R, Caraglia M, et al. Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR. Cancers. 2022; 14(13):3053. https://doi.org/10.3390/cancers14133053

Giunta, Emilio Francesco, Vincenzo De Falco, Pietro Paolo Vitiello, Luigi Pio Guerrera, Gabriella Suarato, Rossella Napolitano, Alessandra Perrone, Giuseppe Argenziano, Renato Franco, Michele Caraglia, and et al. 2022. "Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR" Cancers 14, no. 13: 3053. https://doi.org/10.3390/cancers14133053

Giunta, E. F., De Falco, V., Vitiello, P. P., Guerrera, L. P., Suarato, G., Napolitano, R., Perrone, A., Argenziano, G., Franco, R., Caraglia, M., Martinelli, E., Ciardiello, D., Ciardiello, F., Napolitano, S., & Troiani, T. (2022). Clinical Utility of Liquid Biopsy to Detect BRAF and NRAS Mutations in Stage III/IV Melanoma Patients by Using Real-Time PCR. Cancers, 14(13), 3053. https://doi.org/10.3390/cancers14133053